Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, Iran

Authors Information
Article Notes and Dates
To Cite : Bagheri Lankarani K, Homayon K, Motevalli D, Heidari S T, Alavian S M, et al. Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, Iran, Hepat Mon. 2015 ;15(12):e26407. doi: 10.5812/hepatmon.26407.
Copyright: Copyright © 2015, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Kinjo N, Kawanaka H, Akahoshi T, Matsumoto Y, Kamori M, Nagao Y, et al. Portal vein thrombosis in liver cirrhosis. World J Hepatol. 2014; 6(2): 64-71[DOI][PubMed]
  • 2. Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol. 2014; 11(7): 435-46[DOI][PubMed]
  • 3. Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology. 1985; 89(2): 279-86[PubMed]
  • 4. Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005; 54(5): 691-7[DOI][PubMed]
  • 5. Martinelli I, Primignani M, Aghemo A, Reati R, Bucciarelli P, Fabris F, et al. High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol. 2009; 50(5): 916-22[DOI][PubMed]
  • 6. Chen H, Trilok G, Wang F, Qi X, Xiao J, Yang C. A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors. Indian J Med Res. 2014; 139(2): 260-6[PubMed]
  • 7. Maruyama H, Okugawa H, Takahashi M, Yokosuka O. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol. 2013; 108(4): 568-74[DOI][PubMed]
  • 8. Kakaei F, Nikeghbalian S, Salahi H, Bahador A, Kazemi K, Dehghani M, et al. Liver transplantation in the presence of old portal vein thrombosis. Int J Organ Transplant Med. 2010; 1(1): 44-8[PubMed]
  • 9. Malek-Hosseini SA, Mehdizadeh AR, Salahi H, Saberi-Firouzi M, Bagheri-Lankarani K, Bahador A, et al. Results of liver transplantation: analysis of 140 cases at a single center. Transplant Proc. 2005; 37(7): 3157-8[DOI][PubMed]
  • 10. Qi X, Zhang C, Han G, Zhang W, He C, Yin Z, et al. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol. 2012; 27(6): 1036-43[DOI][PubMed]
  • 11. Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis. 2010; 42(3): 163-70[DOI][PubMed]
  • 12. Mangia A, Villani MR, Cappucci G, Santoro R, Ricciardi R, Facciorusso D, et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol. 2005; 17(7): 745-51[PubMed]
  • 13. D'Amico M, Pasta L, Sammarco P. MTHFR C677TT, PAI1 4G-4G, V Leiden Q506, and prothrombin G20210A in hepatocellular carcinoma with and without portal vein thrombosis. J Thromb Thrombolysis. 2009; 28(1): 70-3[DOI][PubMed]
  • 14. Rodriguez-Castro KI, Porte RJ, Nadal E, Germani G, Burra P, Senzolo M. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation. 2012; 94(11): 1145-53[DOI][PubMed]
  • 15. Gayowski TJ, Marino IR, Doyle HR, Echeverri L, Mieles L, Todo S, et al. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res. 1996; 60(2): 333-8[DOI][PubMed]
  • 16. Thalheimer U, Triantos CK, Samonakis DN, Patch D, Burroughs AK. Infection, coagulation, and variceal bleeding in cirrhosis. Gut. 2005; 54(4): 556-63[DOI][PubMed]
  • 17. Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost. 2011; 9(9): 1713-23[DOI][PubMed]
  • 18. Gatt A, Riddell A, Calvaruso V, Tuddenham EG, Makris M, Burroughs AK. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost. 2010; 8(9): 1994-2000[DOI][PubMed]
  • 19. Tripodi A, Primignani M, Lemma L, Chantarangkul V, Mannucci PM. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. J Hepatol. 2013; 59(2): 265-70[DOI][PubMed]
  • 20. Tripodi A, Primignani M, Lemma L, Chantarangkul V, Dell'Era A, Iannuzzi F, et al. Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology. 2010; 52(1): 249-55[DOI][PubMed]
  • 21. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Sacco M, Martino R, et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy. 2002; 34(7): 535-8[DOI][PubMed]
  • 22. Li XM, Wei YF, Hao HL, Hao YB, He LS, Li JD, et al. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome. Am J Hematol. 2002; 71(1): 11-4[DOI][PubMed]
  • 23. Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, de Franchis R, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology. 2009; 137(6): 2105-11[DOI][PubMed]
  • 24. Nonami T, Yokoyama I, Iwatsuki S, Starzl TE. The incidence of portal vein thrombosis at liver transplantation. Hepatology. 1992; 16(5): 1195-8[PubMed]
  • 25. Lertpipopmetha K, Auewarakul CU. High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis. BMC Gastroenterol. 2011; 11: 66[DOI][PubMed]
  • 26. Sarfeh IJ. Portal vein thrombosis associated with cirrhosis: clinical importance. Arch Surg. 1979; 114(8): 902-5[PubMed]
  • 27. Dultz G, Kronenberger B, Azizi A, Mihm U, Vogl TJ, Sarrazin U, et al. Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura. J Hepatol. 2011; 55(1): 229-32[DOI][PubMed]
  • 28. John BV, Konjeti R, Aggarwal A, Lopez R, Atreja A, Miller C, et al. Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol. 2013; 12(6): 952-8[PubMed]
  • 29. Rossetto V, Spiezia L, Senzolo M, Rodriguez-Castro KI, Gavasso S, Woodhams B, et al. Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? Intern Emerg Med. 2014; 9(4): 397-403[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check